Ampio appoints Dr David Stevens to board
This article was originally published in Scrip
Executive Summary
Ampio Pharmaceuticals, a drugs development company, has appointed Dr David Stevens to its board as an independent director. Dr Stevens is currently executive chairman of Cedus and serves on the board of Poniard Pharmaceuticals, Micro-Imaging Solutions, and Aqua Bounty Technologies. He will replace Michael Macaluso, though Mr Macaluso will retain his position as chairman of the board.